---
title: "DYFFRYN PHARMA LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ad141ab5-2ec2-4f06-b71a-453bf82f3242
json: https://whiteintel.dev/api/public/dossier/ad141ab5-2ec2-4f06-b71a-453bf82f3242
identifier: gb-coh:16498714
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# DYFFRYN PHARMA LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:16498714`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ad141ab5-2ec2-4f06-b71a-453bf82f3242  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ad141ab5-2ec2-4f06-b71a-453bf82f3242  

## Ownership & control

### Owners / controllers

- **WILLIAMS, JENKINS AND WATTS HOLDING LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/f26a2c4c-f3e1-58bd-8820-3e80a0adb085
- **Mr Michael Brooks** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/88cea9ac-af34-435f-8f64-11100a101807

### UBO chain (walk to the ultimate owner)

A **8-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `16498714`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2025-06-05
- **Registered office:** Suite 2d Building 1 Eastern Business Park, St Mellons, Cardiff, CF3 5EA, United Kingdom
- **SIC:** 47730

### Officers

- BROOKS, Michael — director · British · appointed 2026-03-20
- WATTS, Niki Jay — director · British · appointed 2025-06-05
- WILLIAMS, David John — director · British · appointed 2025-06-05 · resigned 2026-03-20

### Beneficial owners (Persons with Significant Control)

- [Williams, Jenkins And Watts Holding Limited](https://whiteintel.dev/entity/f26a2c4c-f3e1-58bd-8820-3e80a0adb085) — 25–50% shares · corporate PSC · United Kingdom — since 2025-06-05
- Mr Michael Brooks — 25–50% shares · individual PSC · United Kingdom — since 2025-06-05

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/16498714

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **DYFFRYN PHARMA LIMITED** — https://whiteintel.dev/entity/ad141ab5-2ec2-4f06-b71a-453bf82f3242 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **DYFFRYN PHARMA LIMITED**. Human view: https://whiteintel.dev/entity/ad141ab5-2ec2-4f06-b71a-453bf82f3242 · Structured JSON: https://whiteintel.dev/api/public/dossier/ad141ab5-2ec2-4f06-b71a-453bf82f3242._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._